

LONDON, Oct 21 (Reuters) - GW Pharmaceuticals' cannabis-derived drug Sativex has been recommended for approval in France for the treatment of spastic...


Britain's small cap equity indexes edge lower on Monday yet outperform bigger falls on the blue-chip index. The FTSE Small Caps Index is down by 0.1 p...


Cannabis-derived drug developer GW Pharmaceuticals has begun human trials of its epilepsy treatment. The AIM- and Nasdaq-listed company said the nov...